COMP <GO>
ACU vs TSLA // REVENUE GROWTH (YOY)
Acme United Corporation. (NYSE) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: ACU 10
— TSLA 3
▲ REVENUE GROWTH (YOY) LEADER: TSLA
LAST: $67.26 (-1.25%) • MKT CAP: $261.1M
revenue-growth
1.10%
LAST: $399.81 (-0.86%) • MKT CAP: $1.59T
revenue-growth
8.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACU VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACU | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.40% | 19.29% | +20.11 | ACU | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.20% | 3.39% | +5.81 | ACU | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.3x | 199.0x | -187.74 | ACU | /valuation <GO> |
| Free Cash Flow Yield | 2.90% | 0.21% | +2.69 | ACU | /fcf-yield <GO> |
| Operating Margin | 7.50% | 3.35% | +4.15 | ACU | /operating-margins <GO> |
| Net Profit Margin | 5.20% | 3.11% | +2.09 | ACU | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 1.10% | 8.30% | -7.20 | TSLA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.90% | 0.00% | +0.90 | ACU | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.72 | 15.35 | -9.63 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | ACU | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 8.72% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.7 | 56.6 | +13.10 | ACU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.89 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.8x | 196.3x | -172.54 | ACU | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $261.1M | $1.59T | -$1.59T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACU REV | TSLA REV | ACU GROSS % | TSLA GROSS % | ACU FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $196.5M | $94.83B | 39.4% | 18.0% | $7.6M | $6.22B |
| FY 2024 | $194.5M | $97.69B | 39.3% | 17.9% | $4.8M | $3.58B |
| FY 2023 | $191.5M | $96.77B | — | 18.3% | $28.9M | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACU // BETA —
TSLA // BETA 1.89